Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems.

Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung carcinoma (NSCLC) subtype. Despite the increased screening efforts, the median five-year survival of metastatic NSCLC remains...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 30; no. 1; pp. 704 - 720
Autores principales:	Doumat, George, Daher, Darine, Zerdan, Morgan Bou, Nasra, Nasri, Bahmad, Hisham F., Recine, Monica, Poppiti, Robert
Formato:	Journal Article
Publicado:	MDPI Jan2023
Acceso en línea:	Ver este registro en EBSCOhost